Skip to main content
. Author manuscript; available in PMC: 2014 Mar 1.
Published in final edited form as: J ECT. 2013 Mar;29(1):3–12. doi: 10.1097/YCT.0b013e31826ea8c4

Table 6.

Oral Dosage and Blood Levels of Continuation Pharmacotherapy Medications by Treatment Condition.

Continuation Pharmacotherapy Group
NT-Li VEN-Li
Mean SD Mean SD
Average Oral Dosage (mg)
NT 87.63 27.78 86.51* 21.18
VEN 286.74* 29.60 275.20 37.42
Li 686.91 219.19 664.08 242.10
Maximum Oral Dosage (mg)
NT 99.11 30.88 93.85* 23.57
VEN 294.64* 24.17 291.39 30.92
Li 816.96 285.92 784.43 300.49
Average Blood Level
NT (ng/ml) 107.99 45.68 104.80* 30.06
Li (mEq/L) 0.51 0.16 0.48 0.17
Maximum Blood Level
NT (ng/ml) 154.60 69.93 122.77* 33.22
Li (mEq/L) 0.71 0.23 0.68 0.27

NT = nortriptyline; VEN = venlafaxine; Li = lithium carbonate.

*

For patient not receiving a medication (e.g., NT for patients treated with VEN-Li) oral dosage reflects the dosage believed to be administered and blood levels reflect dummy values reported to the treating physician.